These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 8097716)

  • 1. Naphthaldehydes as reversible inhibitors of rat hepatic aryl sulfotransferase IV (tyrosine-ester sulfotransferase).
    Duffel MW; Zheng Y
    Drug Metab Dispos; 1993; 21(2):400-2. PubMed ID: 8097716
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of aryl sulfotransferase by carboxylic acids.
    Rao SI; Duffel MW
    Drug Metab Dispos; 1991; 19(2):543-5. PubMed ID: 1676667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-catalyzed irreversible inactivation of rat hepatic aryl sulfotransferase IV by N-hydroxy-2-acetylaminofluorene.
    Mangold BL; Erickson J; Lohr C; McCann DJ; Mangold JB
    Carcinogenesis; 1990 Sep; 11(9):1563-7. PubMed ID: 2401045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of rat hepatic aryl sulphotransferase IV by dihydrodiol derivatives of benzo[a]pyrene and naphthalene.
    Rao SI; Duffel MW
    Xenobiotica; 1992 Feb; 22(2):247-55. PubMed ID: 1632113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification, immunochemical characterization, and immunohistochemical localization of rat hepatic aryl sulfotransferase IV.
    Duffel MW; Binder TP; Hosie L; Baden HA; Sanders JA; Knapp SA; Baron J
    Mol Pharmacol; 1991 Jul; 40(1):36-44. PubMed ID: 1857339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular specificity of aryl sulfotransferase IV (tyrosine-ester sulfotransferase) for xenobiotic substrates and inhibitors.
    Duffel MW
    Chem Biol Interact; 1994 Jun; 92(1-3):3-14. PubMed ID: 8033263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Acetylaminofluorene-mediated alteration in the level of liver arylsulfotransferase IV during rat hepatocarcinogenesis.
    Ringer DP; Norton TR; Howell BA
    Cancer Res; 1990 Sep; 50(17):5301-7. PubMed ID: 2386938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aryl sulfotransferase IV deficiency in rat liver carcinogenesis initiated with diethylnitrosamine and promoted with N-2-fluorenylacetamide or its C-9-oxidized metabolites.
    Malejka-Giganti D; Ringer DP; Vijayaraghavan P; Kiehlbauch CC; Kong J
    Exp Mol Pathol; 1997 Apr; 64(2):63-77. PubMed ID: 9316585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a complementary DNA for rat liver aryl sulfotransferase IV and use in evaluating the hepatic gene transcript levels of rats at various stages of 2-acetylaminofluorene-induced hepatocarcinogenesis.
    Yerokun T; Etheredge JL; Norton TR; Carter HA; Chung KH; Birckbichler PJ; Ringer DP
    Cancer Res; 1992 Sep; 52(17):4779-86. PubMed ID: 1511441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme- and sex-specific differences in the intralobular localizations and distributions of aryl sulfotransferase IV (tyrosine-ester sulfotransferase) and alcohol (hydroxysteroid) sulfotransferase a in rat liver.
    Chen G; Baron J; Duffel MW
    Drug Metab Dispos; 1995 Dec; 23(12):1346-53. PubMed ID: 8689942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the liver carcinogen 2-nitropropane by aryl sulfotransferase.
    Sodum RS; Sohn OS; Nie G; Fiala ES
    Chem Res Toxicol; 1994; 7(3):344-51. PubMed ID: 7521230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzylic alcohols as stereospecific substrates and inhibitors for aryl sulfotransferase.
    Rao SI; Duffel MW
    Chirality; 1991; 3(2):104-11. PubMed ID: 1863522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of rat hepatic sulfotransferase gene expression by glucocorticoid hormones.
    Runge-Morris M; Rose K; Kocarek TA
    Drug Metab Dispos; 1996 Oct; 24(10):1095-101. PubMed ID: 8894510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of rat hepatic aryl sulfotransferase (SULT1A1) gene expression by triamcinolone acetonide: impact on minoxidil-mediated hypotension.
    Duanmu Z; Dunbar J; Falany CN; Runge-Morris M
    Toxicol Appl Pharmacol; 2000 May; 164(3):312-20. PubMed ID: 10799342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of a primary N-hydroxy arylamine with rat hepatic aryl sulfotransferase IV.
    Duffel MW; Modi RB; King RS
    Drug Metab Dispos; 1992; 20(2):339-41. PubMed ID: 1352233
    [No Abstract]   [Full Text] [Related]  

  • 16. Assay of purified aryl sulfotransferase suitable for reactions yielding unstable sulfuric acid esters.
    Duffel MW; Binder TP; Rao SI
    Anal Biochem; 1989 Dec; 183(2):320-4. PubMed ID: 2624319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidation-dependent inactivation of aryl sulfotransferase IV by primary N-hydroxy arylamines during in vitro assays.
    King RS; Duffel MW
    Carcinogenesis; 1997 Apr; 18(4):843-9. PubMed ID: 9111223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of streptozotocin-induced diabetes on rat liver sulfotransferase gene expression.
    Runge-Morris M; Vento C
    Drug Metab Dispos; 1995 Apr; 23(4):455-9. PubMed ID: 7600911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo and in vitro oxidative regulation of rat aryl sulfotransferase IV (AST IV).
    Maiti S; Dutta SM; Baker SM; Zhang J; Narasaraju T; Liu L; Chen G
    J Biochem Mol Toxicol; 2005; 19(2):109-18. PubMed ID: 15849721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethanol up-regulates phenol sulfotransferase (SULT1A1) and hydroxysteroid sulfotransferase (SULT2A1) in rat liver and intestine.
    Maiti S; Chen G
    Arch Physiol Biochem; 2015 May; 121(2):68-74. PubMed ID: 25720860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.